Recent Quarter Total Invested
$371.62 M
Recent Quarter Institutional Ownership Percentage
91.55%
Total Invested of Last Quarter
$1.08 B
Ownership Percentage of Last Quarter
98.18%
Verve Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ALPHABET INC. | 08/02/2024 | 12.35 M | $60.26 M | 0.00% | 14.85% |
| BLACKROCK INC. | 08/13/2024 | 6.62 M | $32.31 M | 23.20% | 7.96% |
| VANGUARD GROUP INC | 08/13/2024 | 5.26 M | $25.69 M | -16.87% | 6.33% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 08/14/2024 | 4.53 M | $22.10 M | -1.04% | 5.45% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 3.87 M | $18.89 M | 529.99% | 4.66% |
| STATE STREET CORP | 08/14/2024 | 3.35 M | $16.35 M | -34.29% | 4.03% |
| CASDIN CAPITAL, LLC | 10/18/2024 | 3.06 M | $14.93 M | 0.00% | 3.68% |
| ARK INVESTMENT MANAGEMENT LLC | 07/26/2024 | 2.94 M | $14.33 M | -51.39% | 3.53% |
| NOVO HOLDINGS A/S | 08/20/2024 | 2.40 M | $11.71 M | 20.00% | 2.89% |
| ARCH VENTURE MANAGEMENT, LLC | 08/14/2024 | 2.01 M | $9.80 M | 0.00% | 2.42% |
| BAKER BROS. ADVISORS LP | 08/14/2024 | 1.69 M | $8.25 M | 0.00% | 2.03% |
| JPMORGAN CHASE & CO | 08/12/2024 | 1.69 M | $8.25 M | 13.28% | 2.03% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 1.56 M | $7.61 M | 7.61% | 1.88% |
| REDMILE GROUP, LLC | 08/14/2024 | 1.46 M | $7.14 M | -8.79% | 1.76% |
| FMR LLC | 08/13/2024 | 1.42 M | $6.91 M | -58.10% | 1.70% |
| GOLDMAN SACHS GROUP INC | 08/13/2024 | 1.29 M | $6.29 M | 55.05% | 1.55% |
| ECOR1 CAPITAL, LLC | 08/14/2024 | 1.25 M | $6.10 M | 0.00% | 1.50% |
| FEDERATED HERMES, INC. | 08/08/2024 | 1.15 M | $5.62 M | -67.62% | 1.39% |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 07/19/2024 | 1.12 M | $5.44 M | -56.97% | 1.34% |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 08/09/2024 | 1.12 M | $5.43 M | -56.97% | 1.34% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 08/14/2024 | 905,815 | $4.42 M | 100.00% | 1.09% |
| NUVEEN ASSET MANAGEMENT, LLC | 08/09/2024 | 810,497 | $3.96 M | -7.39% | 0.97% |
| BVF INC/IL | 08/14/2024 | 650,000 | $3.17 M | 0.00% | 0.78% |
| BIOIMPACT CAPITAL LLC | 08/14/2024 | 638,163 | $3.11 M | 0.00% | 0.77% |
| MORGAN STANLEY | 10/17/2024 | 623,730 | $3.04 M | -29.57% | 0.75% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2024 | 607,473 | $2.96 M | 147.36% | 0.73% |
| PALO ALTO INVESTORS LP | 08/14/2024 | 575,817 | $2.81 M | 0.00% | 0.69% |
| NORTHERN TRUST CORP | 08/14/2024 | 572,223 | $2.79 M | -1.47% | 0.69% |
| TREXQUANT INVESTMENT LP | 08/13/2024 | 523,393 | $2.55 M | 221.57% | 0.63% |
| CITADEL ADVISORS LLC | 08/14/2024 | 507,360 | $2.48 M | -56.90% | 0.61% |
| VESTAL POINT CAPITAL, LP | 08/14/2024 | 500,000 | $2.44 M | 100.00% | 0.60% |
| RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 474,500 | $2.32 M | 138.05% | 0.57% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 473,016 | $2.31 M | 26.74% | 0.57% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 446,063 | $2.18 M | -8.41% | 0.54% |
| DIMENSIONAL FUND ADVISORS LP | 08/09/2024 | 436,388 | $2.13 M | -11.19% | 0.52% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 09/16/2024 | 395,699 | $1.93 M | 245.51% | 0.48% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2024 | 371,300 | $1.81 M | 46.74% | 0.45% |
| CORMORANT ASSET MANAGEMENT, LP | 08/14/2024 | 350,000 | $1.71 M | 0.00% | 0.42% |
| PDT PARTNERS, LLC | 08/15/2024 | 333,864 | $1.63 M | 75.16% | 0.40% |
| BANK OF NEW YORK MELLON CORP | 07/25/2024 | 274,873 | $1.34 M | 22.19% | 0.33% |
| JANE STREET GROUP, LLC | 08/15/2024 | 253,800 | $1.24 M | 835.05% | 0.31% |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 08/05/2024 | 242,468 | $1.18 M | 100.00% | 0.29% |
| TWO SIGMA ADVISERS, LP | 08/14/2024 | 238,700 | $1.16 M | 550.41% | 0.29% |
| RAFFERTY ASSET MANAGEMENT, LLC | 08/13/2024 | 226,348 | $1.10 M | -52.21% | 0.27% |
| GSA CAPITAL PARTNERS LLP | 08/15/2024 | 203,677 | $994,000 | 100.00% | 0.25% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 192,406 | $938,941 | 266.32% | 0.23% |
| AMERIPRISE FINANCIAL INC | 08/14/2024 | 179,418 | $875,560 | 79.49% | 0.22% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 08/14/2024 | 144,027 | $702,177 | 100.00% | 0.17% |
| GRAHAM CAPITAL MANAGEMENT, L.P. | 08/14/2024 | 142,514 | $695,468 | 397.57% | 0.17% |
| ALGERT GLOBAL LLC | 08/15/2024 | 137,496 | $671,000 | 100.00% | 0.17% |
Verve Therapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of VERV shares?
During the previous two years, 192 institutional investors and hedge funds held shares of Verve Therapeutics, Inc.. The most heavily invested institutionals were:
Alphabet Inc.: 12.35 M
BlackRock Funding, Inc. /DE: 7.28 M
MILLENNIUM MANAGEMENT LLC: 4.96 M
STATE STREET CORP: 4.25 M
Casdin Capital, LLC: 4 M
T. Rowe Price Investment Management, Inc.: 2.43 M
-
What percentage of Verve Therapeutics, Inc. stock is owned by institutional investors?
91.55% of Verve Therapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at VERV ?
Institutional investors have bought a total of 75.77 M shares in the last 24 months. This purchase volume represents approximately $356.86 M in transactions.